Quantra® Viscoelastic Testing in Pediatric Trauma: A Review of Emerging Evidence and Clinical Integration

Chris Deskins1, Samantha Smith1, Patrick C Bonasso2

  • 1Anesthesiology, West Virginia University, Morgantown, USA.

Cureus
|December 15, 2025
PubMed

Insights

Early recognition of trauma-induced coagulopathy (TIC) in children is vital. The Quantra system offers rapid viscoelastic hemostatic assay (VHA) assessment, potentially improving pediatric trauma resuscitation, though further validation is needed.

Area of Science:

  • Traumatology
  • Hemostasis
  • Point-of-care diagnostics

Background:

  • Trauma-induced coagulopathy (TIC) significantly impacts pediatric survival rates.
  • Conventional coagulation tests (PT/INR, fibrinogen) offer delayed and incomplete assessments.
  • Rapid, comprehensive coagulation monitoring is crucial for effective pediatric trauma management.

Purpose of the Study:

  • To review the current evidence on the Quantra® System's utility in pediatric trauma.
  • To compare Quantra® with established viscoelastic hemostatic assays (VHAs) like TEG® and ROTEM®.
  • To discuss the emerging role of Quantra® in perioperative care and trauma resuscitation.

Main Methods:

  • Literature review of studies involving Quantra® use in pediatric trauma.
  • Comparative analysis of Quantra® data with conventional VHAs (TEG®, ROTEM®).
  • Examination of preliminary data on Quantra®'s application in clinical settings.

Main Results:

  • The Quantra® System provides a rapid, simple, and standardized assessment of coagulation.
  • Preliminary data shows good correlation between Quantra® and conventional VHAs.
  • Quantra® offers a potentially faster alternative for assessing coagulation in pediatric trauma.

Conclusions:

  • The Quantra® System shows promise for real-time coagulation assessment in pediatric trauma resuscitation.
  • Further large-scale pediatric validation studies are essential.
  • Optimizing transfusion algorithms and assessing patient outcomes require further research.